Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -210.75% is 59% above its 5-year average of -509.98%, near the high end of its 5-year range (-5982.80%–-111.69%).
14.58% above its 12-month average of -246.71%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -238.17%.
NET PROFIT MARGIN
-210.75%
NET PROFIT MARGIN AVG TTM
-246.71%
NET PROFIT MARGIN AVG 3Y
-319.85%
NET PROFIT MARGIN AVG 5Y
-509.98%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+14.58%
CURRENT VS 3Y AVG
+34.11%
CURRENT VS 5Y AVG
+58.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 690 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Hyperfine, Inc.
Market Cap
$76.53M
Net Profit Margin
-210.75%
TTM Avg
-246.71%
3Y Avg
-319.85%
5Y Avg
-509.98%
Market Cap
$77.29M
Net Profit Margin
-63.06%
TTM Avg
-90.45%
3Y Avg
-113.67%
5Y Avg
-137.76%
Market Cap
$77.80M
Net Profit Margin
-155404.38%
TTM Avg
-155404.38%
3Y Avg
-155404.38%
5Y Avg
-155404.38%
Market Cap
$78.76M
Net Profit Margin
-130000.00%
TTM Avg
-89627.13%
3Y Avg
-49555.20%
5Y Avg
-36262.68%
Market Cap
$74.00M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-13227.36%
5Y Avg
-12286.00%
Market Cap
$80.04M
Net Profit Margin
-55.03%
TTM Avg
-63.48%
3Y Avg
-81.34%
5Y Avg
-87.39%
Market Cap
$80.89M
Net Profit Margin
-648.32%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$81.57M
Net Profit Margin
-430.43%
TTM Avg
-446.97%
3Y Avg
-347.08%
5Y Avg
-386.84%
Market Cap
$70.95M
Net Profit Margin
-105.29%
TTM Avg
-106.48%
3Y Avg
-112.00%
5Y Avg
-95.88%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hyperfine, Inc. (HYPR) | $76.53M | -210.75% | -246.71% | -319.85% | -509.98% |
| Outset Medical, Inc. (OM)vs › | $77.29M | -63.06% | -90.45% | -113.67% | -137.76% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.80M | -155404.38% | -155404.38% | -155404.38% | -155404.38% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.76M | -130000.00% | -89627.13% | -49555.20% | -36262.68% |
| Gain Therapeutics, Inc. (GANX)vs › | $74.00M | 0.00% | 0.00% | -13227.36% | -12286.00% |
| Pulmonx Corporation (LUNG)vs › | $80.04M | -55.03% | -63.48% | -81.34% | -87.39% |
| Citius Oncology, Inc. (CTOR)vs › | $80.89M | -648.32% | 0.00% | 0.00% | 0.00% |
| Nutriband Inc. (NTRB)vs › | $81.57M | -430.43% | -446.97% | -347.08% | -386.84% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.95M | -105.29% | -106.48% | -112.00% | -95.88% |
| LENSAR Inc (LNSR)vs › | $82.41M | 57.57% | -58.69% | -51.95% | -56.60% |
Operating Margin
-273.4%
Net Profit Margin
-210.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -238.17% |
| 2026-03-31 | -220.93% |
| 2025-12-31 | -111.69% |
| 2025-09-30 | -320.60% |
| 2025-06-30 | -342.17% |
| 2025-03-31 | -440.71% |
| 2024-12-31 | -447.65% |
| 2024-09-30 | -283.45% |
| 2024-06-30 | -279.70% |
| 2024-03-31 | -298.88% |
| 2023-12-31 | -397.77% |
| 2023-09-30 | -461.67% |
| 2023-06-30 | -314.61% |
| 2023-03-31 | -461.48% |
| 2022-12-31 | -917.06% |
| 2022-09-30 | -560.95% |
| 2022-06-30 | -1506.46% |
| 2022-03-31 | -1575.75% |
| 2021-12-31 | -5982.80% |
| 2021-09-30 | -4418.33% |
| 2021-06-30 | -4072.63% |
| 2021-03-31 | -2354.68% |
| 2020-12-31 | -3314.98% |
| 2020-09-30 | -15329.73% |
| 2020-06-30 | -21786.00% |
| 2020-03-31 | -21786.00% |
